Abstract
Argininosuccinate synthetase (ASS) is a urea cycle enzyme that forms argininosuccinate from citrulline and aspartate. Mutations at the ASS locus in man cause the inherited disease, citrullinemia. Citrullinemia is inherited as an autosomal recessive trait and is characterized, biochemically, by elevated levels of blood citrulline and ammonia and often results in early neonatal death if untreated. We have used homologous recombination in embryonic stem cells to generate a line of mice having a targeted disruption of theAss gene. Homozygous mutant animals develop high levels of blood citrulline, become hyperammonemic, and die within one or two days after birth. Because the phenotype of the mutant mice closely resembles that of humans who lack the ASS enzyme, we expect that these mice will serve as a useful model for exploring new treatments for citrullinemia including somatic gene therapy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Literature Cited
McMurray, W.C., Mohyuddin, F., Rossiter, R.M., Rathbun, J.C., Valentine, G.H., Koegler, S.J., and Zarfas, D.E. (1962).Lancet 1:138.
Brusilow, S.W., and Horwich, A.L. (1989). InThe Metabolic Basis of Inherited Disease, (eds.) Scriver, C.R., Beaudet, A.L., Sly, W.S., and Valle,D. (McGraw-Hill, New York), pp. 629–663.
Beaudet, A.L., O'Brien, W.E., Bock, H.-G.O., Freytag, S.O., and Su, T.-S. (1986).Adv. Hum Genet. 15:161–196.
Kobayashi, K., Rosenbloom, C., Beaudet, A.L., and O'Brien, W.E. (1991).Mol. Biol. Med. 8:95–100.
Kobayashi, K., Jackson, M.J., Tick, D.B., O'Brien, W.E., and Beaudet, A.L. (1990).J. Biol. Chem. 265:11361–11367.
Jackson, M.J., Surh, L.C., O'Brien, W.E., and Beaudet, A.L. (1990).Genomics 6:545–547.
Harper, P.A.W., Healy, P.J., Dennis, J.A., O'Brien, J.J., and Rayward, D.H. (1986).Aust. Vet. J. 63:378–379.
Dennis, J.A., Healy, P.J., Beaudet, A.L., and O'Brien, W.E. (1989).Proc. Natl. Acad. Sci. U.S.A. 86:7947–7951.
Thomas, K.R. and Capecchi, M.R. (1987).Cell 51:503–512.
Surh, L.C., Beaudet, A.L., and O'Brien, W.E. (1991).Gene 99:181–189.
Soriano, P., Montgomery, C., Geske, R., and Bradley, A. (1991).Cell 64:693–702.
Mansour, S.L., Thomas, K.R., and Capecchi, M.R. (1988).Nature 336:348–352.
McMahon, A.P., and Bradley, A. (1990).Cell 62:1073–1085.
Bradley, A. (1990).Curr. Opin. Cell. Biol. 2:1013–1017.
Ramirez-Solis, R., Rivera-Perez, J., Wallace, J.D., Wims, M., Zheng, H., and Bradley, A. (1992).Anal. Biochem. 201:331–335.
Su, T-S., Beaudet, A.L., and O'Brien, W.E. (1981).Biochemistry 20:2956–2960.
Batshaw, M.L., Hyman, S.L., Mellits, E.D., Thomas, G.H., DeMuro, R., and Coyle, J.T. (1986).Pediatr. Res. 20:1310–1315.
DeMars, R., LeVan, S.L., Trend, B., Russell, L.B. (1976).Proc. Natl. Acad. Sci. U.S.A. 73:1693–1697.
Stratford-Perricaudet, L.D., Levrero, M., Chasse, J-F., Perricaudet, M., and Briand, P. (1990).Hum. Genet Ther. 1:241–256.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Patejunas, G., Bradley, A., Beaudet, A.L. et al. Generation of a mouse model for citrullinemia by targeted disruption of the argininosuccinate synthetase gene. Somat Cell Mol Genet 20, 55–60 (1994). https://doi.org/10.1007/BF02257486
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02257486